Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: day (1000), time (1000)

BEACOPP 14

Description: Chemotherapy Protocol LYMPHOMA BLEOMYCIN-CYCLOPHOSPHAMIDE-DOXORUBICIN-ETOPOSIDE-PREDNISOLONEPROCARBAZINE-VINCRISTINE (BEACOPP-14) Regimen • Lymphoma – BEACOPP-14-Bleomycin-Cyclophosphamide-Doxorubicin-EtoposidePrednisolone-Procarbazine-Vincristine
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/BEACOPP-14.pdf

BEACOPDac escalated

Description: Chemotherapy Protocol LYMPHOMA BLEOMYCIN-CYCLOPHOSPHAMIDE-DACARBAZINE-DOXORUBICIN-ETOPOSIDEPREDNISOLONE-VINCRISTINE (BEACOPDac Escalated) Regimen • Lymphoma – BEACOPDac Escalated-Bleomycin-Cyclophosphamide-DacarbazineDoxorubicin-Etoposide-Prednisolone-Vincristine
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/BEACOPDac-escalated.pdf

Pembrolizumab (200mg)

Description: Regimen Chemotherapy Protocol HEAD AND NECK CANCER Pembrolizumab (200mg) • Head and Neck – Pembrolizumab (200mg) Indication • Pembrolizumab is recommended in in adult
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Pembrolizumab-200mg.pdf

Pembrolizumab (400mg) head and neck

Description: Chemotherapy Protocol HEAD AND NECK CANCER Pembrolizumab (400mg) Regimen • Head and Neck – Pembrolizumab (400mg) Indication • Pembrolizumab is recommended in in adult
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Pembrolizumab-400mg-head-and-neck.pdf

MDT Leaflet_Young Lives vs Cancer Eligibility Criteria 2021

Description: YOUNG LIVES VS CANCER ELIGIBILITY FOR HEALTH PROFESSIONALS YOUNG LIVES VS CANCER: WHO WE ARE Cancer is shocking, overwhelming, isolating... and
Url: /Media/UHS-website-2019/Docs/Services/Cancer-care/mdt-leaflet-young-lives-vs-cancer-eligibility-criteria-2021.pdf

Financial advice and assistance - patient information

Description: If your child has a disability or long-term health condition, or if you are on a low income, you may
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Financial-advice-and-assistance-2442-PIL.pdf

Keeping your baby safe - patient information

Description: We have written this factsheet to make sure your baby is cared for as safely as possible, outside and at home
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Keeping-your-baby-safe.pdf

Supplier representative procedure

Description: Procurement and supply chain and the commercial development team appreciate the role that companies play to assist the Trust in providing
Url: /Media/UHS-website-2019/Docs/Policies/Supplier-representative-procedure.pdf

Docetaxel-Pertuzumab/TrastuzumabSC

Description: Chemotherapy Protocol BREAST CANCER Docetaxel-Pertuzumab/Trastuzumab SC Regimen • Breast Cancer – Docetaxel-Pertuzumab/Trastuzumab SC Indication • Treatment of metastatic breast cancer
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Docetaxel-PertuzumabTrastuzumabSC.pdf

Featured research: MS-STAT2 study

Description: Auto Generated Title Is Simvastatin an effective treatment for Secondary Progressive Multiple Scler
Url: /ClinicalResearchinSouthampton/Public-and-patients/Featured-research-studies/Featured-research-MS-STAT2-study.aspx

651 to 660 of 986

Previous … 64 65 66 67 68 … Next